Disk-Diffusion Testing Is an Inappropriate Screening Tool for Cephalosporin-Resistant Gonorrhoea Strains in Clinical Practice in China

References

• Newman L, Rowley J, Vander Hoorn S, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One. 2015;10(12):e0143304. doi:10.1371/journal.pone.014330426646541
   PubMed Web of Science ®Google Scholar
• Brunham RC, Gottlieb SL, Paavonen J, Campion EW. Pelvic inflammatory disease. N Engl J Med. 2015;372(21):2039–2048. doi:10.1056/NEJMra141142625992748
   PubMed Web of Science ®Google Scholar
• Hook EW 3rd, Handsfield HH. Gonococcal infections in the adult In: Holmes KK, Sparling PF, Mardh PA, Lemon SM, Stamm WE, Piot P, Wasserheit JN, eds. Sexually Transmitted Diseases. 3rd ed. New York: McGraw-Hill; 1999:451–466.
   Google Scholar
• Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet. 1997;349(9069):1868–1873. doi:10.1016/S0140-6736(97)02190-99217758
   PubMed Web of Science ®Google Scholar
• Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014;27:587–613.24982323
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Cephalosporin susceptibility among Neisseria gonorrhoeae isolates: United States, 2000–2010. MMWR Morb Mortal Wkly Rep. 2011;60(26):873–877.21734634
   PubMedGoogle Scholar
• Yin Y-P, Han Y, Dai X-Q, et al. Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: a retrospective study of national surveillance data from 2013 to 2016. PLoS Med. 2018;15(2):e1002499. doi:10.1371/journal.pmed.100249929408881
   PubMed Web of Science ®Google Scholar
• Chen S-C, Yin Y-P, Chen X-S. Cephalosporin-resistant Neisseria gonorrhoeae clone, China. Emerg Infect Dis. 2018;24(4):804–806. doi:10.3201/eid2404.17181729553336
   PubMed Web of Science ®Google Scholar
• Yokoi S, Deguchi T, Ozawa T, et al. Threat to cefixime treatment for gonorrhea. Emerg Infect Dis. 2007;13(8):1275–1277. doi:10.3201/eid1308.06094817953118
   PubMed Web of Science ®Google Scholar
• Ohnishi M, Golparian D, Shimuta K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother. 2011;55:3538–3545.21576437
   PubMed Web of Science ®Google Scholar
• Unemo M, Golparian D, Potočnik M, et al. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Euro Surveill. 2012;17:20200.22748003
   PubMedGoogle Scholar
• Allen VG, Mitterni L, Seah C, et al. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA. 2013;309(2):163–170. doi:10.1001/jama.2012.17657523299608
   PubMed Web of Science ®Google Scholar
• Han Y, Yin Y, Dai X, et al. Widespread use of high-dose ceftriaxone therapy for uncomplicated gonorrhea without reported ceftriaxone treatment failure: results from 5 years of multicenter surveillance data in China. Clin Infect Dis. 2020;70(1):99–105. doi:10.1093/cid/ciz17030838398
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 29th edition; 2018 Available from: https://clsi.org/standards/products/microbiology/documents/m100/. Accessed 527, 2019.
   Google Scholar
• Lautenbach E, Patel JB, Bilker WB, et al. Extended-spectrum b-lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001;32(8):1162–1171. doi:10.1086/31975711283805
   PubMed Web of Science ®Google Scholar
• Bauer AW, Kirby WM, Sherris JC, et al. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45(4_ts):493–496. doi:10.1093/ajcp/45.4_ts.4935325707
   PubMed Web of Science ®Google Scholar
• Mal PB, Jabeen K, Farooqi J, et al. Antimicrobial susceptibility testing of Neisseria gonorrhoeae isolates in Pakistan by etest compared to calibrated dichotomous sensitivity and clinical laboratory standards institute disc diffusion techniques. BMC Microbiol. 2016;16(1):236. doi:10.1186/s12866-016-0707-627724873
   PubMed Web of Science ®Google Scholar
• Liu H, Taylor TH Jr, Pettus K, et al. Comparing the disk-diffusion and agar dilution tests for Neisseria gonorrhoeae antimicrobial susceptibility testing. Antimicrob Resist Infect Control. 2016;5(1):46.eCollection 2016. doi:10.1186/s13756-016-0148-x
   Web of Science ®Google Scholar
• U.S. Food and Drug Administration. Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) Systems. U.S. Department of Health and Human Services Food and Drug Administration, Center for Devices and Radiological Health; 2007 Available from: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm080187.htm. Accessed 619, 2020.
   Google Scholar
• Wu X, Qin X, Huang J, et al. Determining the in vitro susceptibility of Neisseria gonorrhoeae isolates from 8 cities in Guangdong Province through an improved microdilution method. Diagn Microbiol Infect Dis. 2018;92(4):325–331. doi:10.1016/j.diagmicrobio.2018.06.00430292397
   PubMed Web of Science ®Google Scholar
• Wi T, Lahra MM, Ndowa F, et al. Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action. PLoS Med. 2017;14(7):e1002344. doi:10.1371/journal.pmed.100234428686231
   PubMed Web of Science ®Google Scholar
• Kirkcaldy RD, Harvey A, Papp JR, et al. Neisseria gonorrhoeae antimicrobial susceptibility surveillance — the gonococcal isolate surveillance project, 27 sites, United States, 2014. MMWR Surveill Summ. 2016;65(7):1–19. doi:10.15585/mmwr.ss6507a1
   PubMed Web of Science ®Google Scholar
• Cole MJ, Unemo M, Hoffmann S, et al. The European gonococcal antimicrobial surveillance programme, 2009. Euro Surveill. 2011;16:19995.22027378
   PubMedGoogle Scholar
• Liao CH, Lai CC, Hsu MS, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates determined by the agar dilution, disk diffusion and Etest methods: comparison of results using GC agar and chocolate agar. Int J Antimicrob Agents. 2010;35(5):457–460. doi:10.1016/j.ijantimicag.2010.01.00720188518
   PubMed Web of Science ®Google Scholar
• Singh V, Bala M, Kakran M, et al. Comparative assessment of CDS, CLSI disc diffusion and Etest techniques for antimicrobial susceptibility testing of Neisseria gonorrhoeae: a 6-year study. BMJ Open. 2012;2(4):e000969. doi:10.1136/bmjopen-2012-000969
   Web of Science ®Google Scholar
• Liu H, Taylor TH Jr, Pettus K, et al. Assessment of Etest as an alternative to agar dilution for antimicrobial susceptibility testing of Neisseria gonorrhoeae. J Clin Microbiol. 2014;52(5):1435–1440. doi:10.1128/JCM.02131-1324554750
   PubMed Web of Science ®Google Scholar